NCT00234338已完成不适用
Prospective Post-Marketing Surveillance Study of Prevenar in High-Risk Children Aged 2 to 5 Years
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 5,000 人开始时间: 2005年10月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 5,000
研究概览
简要总结
The purpose of this study is to estimate the local and systemic tolerability of Prevenar in children ages 2 to 5 years old in usual care settings.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Years 至 5 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •High-risk children ages 2 to 5 years old
- •Exclusion criteria:
- •Prior administration of Prevenar
- •Prior and/or concurrent administration of 23 vPs vaccine
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Safety and Local Tolerability of Prevenar in Indian ChildrenPneumococcal InfectionsNCT00488800Wyeth is now a wholly owned subsidiary of Pfizer1,000
已完成
不适用
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal WomenPostmenopauseNCT00484107Wyeth is now a wholly owned subsidiary of Pfizer200
已完成
不适用
Prevenar13 Post Market SurveillanceHealthyNCT01509105Pfizer649
招募中
不适用
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasNCT04750798Biosense Webster, Inc.8,000
已完成
不适用
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsArthritis, PsoriaticPsoriasisSkin Diseases, PapulosquamousNCT00293722Pfizer1,308